Case Presentation: Lung Consolidation as Sequelae of BCG Sepsis After Combined Intravesical and Intraurethral BCG

Jeffrey Strich; Sam Brancato; Rebecca Dolan; Mahir Maruf; Mohammad R Siddiqui; Thomas Sanford; Christa Zerbe; Piyush K Agarwal

doi:10.1016/j.eucr.2017.04.009

Case Presentation: Lung Consolidation as Sequelae of BCG Sepsis After Combined Intravesical and Intraurethral BCG

Urol Case Rep. 2017 May 22:13:152-153. doi: 10.1016/j.eucr.2017.04.009. eCollection 2017 Jul.

Authors

Jeffrey Strich¹, Sam Brancato², Rebecca Dolan², Mahir Maruf², Mohammad R Siddiqui², Thomas Sanford², Christa Zerbe¹, Piyush K Agarwal²

Affiliations

¹ Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
² Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Abstract

BCG sepsis is rarely seen with modern intravesical therapy and therefore its presentation may not be apparent to recently trained urologists. We describe BCG sepsis occurring in a patient treated with combined intravesical and intraurethral BCG which resulted in lung consolidation with acid-fast bacilli requiring cessation of BCG and initiation of systemic antibiotic therapy.

Keywords: BCG; Sepsis; Urethral carcinoma.

Publication types

Case Reports

Grants and funding

ZIA BC011528/Intramural NIH HHS/United States